Man Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$457K Buy
+25,395
New +$509K ﹤0.01% 2113
2025
Q4
Sell
-10,780
Closed -$215K 2486
2025
Q3
$215K Sell
10,780
-3,505
-25% -$62.9K ﹤0.01% 2091
2025
Q2
$196K Buy
+14,285
New +$137K ﹤0.01% 2077
2023
Q2
Hold
0
-$149K 2237
2023
Q1
Sell
-14,300
Closed -$132K 1879
2022
Q4
$127K Buy
+14,300
New +$135K ﹤0.01% 1872
2019
Q3
Sell
-16,484
Closed -$592K 1920
2019
Q2
$592K Sell
16,484
-162,512
-91% -$5.99M ﹤0.01% 1638
2019
Q1
$6.61M Buy
178,996
+59,260
+49% +$2.48M 0.03% 766
2018
Q4
$5.16M Buy
119,736
+13,188
+12% +$593K 0.02% 753
2018
Q3
$5.03M Buy
106,548
+85,416
+404% +$3.97M 0.02% 992
2018
Q2
$1.05M Buy
+21,132
New +$1.23M ﹤0.01% 1595

Other funds holding URGN